technetium tc 99m sestamibi has been researched along with Angiogenesis, Pathologic in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (50.00) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asa, SL; Erovic, BM; Goldstein, DP; Irish, JC; Janik, S; Mete, O | 1 |
| Ahn, SJ; Chung, JK; Chung, KW; Im, JG; Kim, SW; Moon, WK; Noh, DY; Park, SS; Yeo, JS | 1 |
| Del Vecchio, S; Salvatore, M | 1 |
| Blomberg, P; Bøtker, HE; Drvota, V; Dudek, D; Glogar, D; Gyöngyösi, M; Hesse, B; Jørgensen, E; Kastrup, J; Rück, A; Ruzyllo, W; Sylvén, C; Tägil, K; Thuesen, L | 1 |
| Aydin, A; Bekiş, R; Canda, T; Degirmenci, B; Durak, H; Ozdogan, O | 1 |
| Fukuoka, M; Kinuya, S; Michigishi, T; Mori, H; Shiba, K; Shuke, N; Tonami, N; Watanabe, N; Yokoyama, K | 1 |
| Banci, M; Centi Colella, A; Danieli, R; Di Macio, L; Limiti, MR; Mingazzini, PL; Scarpini, M; Schillaci, O; Scopinaro, F; Zerilli, M | 1 |
| Bourgeois, P | 1 |
| Brasseur, N; Lewis, K; Rousseau, J; van Lier, JE | 1 |
| Cutrone, JA; Devito, A; Diggles, L; French, S; Khalkhali, I; Shitabata, P; Tolmos, J; Vargas, MP; Yospur, LS | 1 |
| Bom, HS; Jaegal, YJ; Lee, JH; Song, HC; Yoon, JH | 1 |
| Benevolo, M; Botti, C; Festa, A; Giunta, S; Maini, CL; Mottolese, M; Pasqualoni, R; Sciuto, R; Semprebene, A; Tofani, A | 1 |
| Fukuda, H; Harada, Y; Kubota, K; Ohira, H; Ohuchi, N; Satomi, S | 1 |
| Chen, J; Chen, S; Yin, Y | 1 |
1 review(s) available for technetium tc 99m sestamibi and Angiogenesis, Pathologic
| Article | Year |
|---|---|
99mTc-MIBI in the evaluation of breast cancer biology.
Topics: Animals; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers, Tumor; Breast Neoplasms; False Negative Reactions; False Positive Reactions; Humans; Neovascularization, Pathologic; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2004 |
2 trial(s) available for technetium tc 99m sestamibi and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Identification of angiogenesis in primary breast carcinoma according to the image analysis.
Topics: Adult; Aged; Breast Neoplasms; Endothelial Growth Factors; Female; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Male; Mammography; Middle Aged; Neovascularization, Pathologic; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Technetium Tc 99m Sestamibi; Ultrasonography, Doppler; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial.
Topics: Angina Pectoris; Double-Blind Method; Europe; Exercise Test; Female; Genetic Therapy; Humans; Male; Middle Aged; Neovascularization, Pathologic; Plasmids; Radiopharmaceuticals; Severity of Illness Index; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Vascular Endothelial Growth Factor A; Ventricular Dysfunction, Left | 2005 |
11 other study(ies) available for technetium tc 99m sestamibi and Angiogenesis, Pathologic
| Article | Year |
|---|---|
VEGFR-2 is downregulated in sestamibi-negative parathyroid adenomas.
Topics: Aged; Cohort Studies; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Neovascularization, Pathologic; Parathyroid Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Reference Values; Sensitivity and Specificity; Signal Transduction; Technetium Tc 99m Sestamibi; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor Receptor-2 | 2019 |
Correlation between 99mTc-MIBI uptake and angiogenesis in MIBI-positive breast lesions.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Middle Aged; Neovascularization, Pathologic; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2005 |
Anti-angiogenic therapy and chemotherapy affect 99mTc sestamibi and 99mTc-HL91 accumulation differently in tumour xenografts.
Topics: 2-Methoxyestradiol; Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Estradiol; Fluorouracil; Humans; Hypoxia; Kinetics; Mice; Neoplasm Transplantation; Neovascularization, Pathologic; Organotechnetium Compounds; Oximes; Oxygen; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Time Factors | 2005 |
Technetium-99m sestamibi: an indicator of breast cancer invasiveness.
Topics: Adult; Aged; Breast; Breast Neoplasms; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neovascularization, Pathologic; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1994 |
The use of technetium-99m sestamibi to indicate breast cancer invasiveness.
Topics: Breast; Breast Neoplasms; Female; Humans; Lymphatic Metastasis; Neoplasm Invasiveness; Neoplasm Staging; Neovascularization, Pathologic; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1995 |
Measurement of tumor vascular damage in mice with 99mTc-MIBI following photodynamic therapy.
Topics: Animals; Contrast Media; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neovascularization, Pathologic; Perfusion; Photochemotherapy; Technetium Tc 99m Sestamibi | 1996 |
Immunohistologic assessment of technetium-99m-MIBI uptake in benign and malignant breast lesions.
Topics: Breast; Breast Diseases; Breast Neoplasms; Female; Humans; Neovascularization, Pathologic; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 1998 |
Double-phase Tc-99m sestamibi scintimammography to assess angiogenesis and P-glycoprotein expression in patients with untreated breast cancer.
Topics: Adult; Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers, Tumor; Breast; Breast Neoplasms; Breast Neoplasms, Male; Female; Humans; Immunohistochemistry; Male; Middle Aged; Neovascularization, Pathologic; Prospective Studies; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1999 |
99Tcm-MIBI scintimammography in 300 consecutive patients: factors that may affect accuracy.
Topics: Adult; Aged; Breast Neoplasms; False Negative Reactions; False Positive Reactions; Female; Humans; Mammography; Middle Aged; Neovascularization, Pathologic; Postmenopause; Premenopause; Proliferating Cell Nuclear Antigen; Radionuclide Imaging; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Reproducibility of Results; Technetium Tc 99m Sestamibi | 1999 |
Comparison of intratumoral distribution of 99mTc-MIBI and deoxyglucose in mouse breast cancer models.
Topics: Animals; Biological Transport; Carbon Radioisotopes; Carcinoma, Ehrlich Tumor; Deoxyglucose; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Microcirculation; Neovascularization, Pathologic; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tissue Distribution; X-Rays | 2000 |
[Correlation between accumulation of (99m)Tc-MIBI in breast cancer or benign lesion, cell proliferation and angiogenesis].
Topics: Adult; Breast; Breast Neoplasms; Cell Division; Female; Humans; Immunohistochemistry; Middle Aged; Neovascularization, Pathologic; Proliferating Cell Nuclear Antigen; Radionuclide Imaging; Regression Analysis; Technetium Tc 99m Sestamibi | 1998 |